Clinical Trials Browser

Phase 2/3 × OTHER × Positron Emission Tomography Computed Tomography × Clear all

NCT04552847 2022-02-17

Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors

Phase 2/3 Completed

Neuroendocrine Tumors

NCT03564704 2018-06-21

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

Phase 2/3 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma